






















![]()
Q1: 2026-05-04 Earnings Summary
EPS of -$1.26 misses by $0.40
|
Revenue of
$191.20M
(57.42% Y/Y)
beats by $509.10K
Axsome Therapeutics, Inc. (AXSM) Q1 2026 Earnings Call May 4, 2026 8:00 AM EDT
Company Participants
Ashley Dong
Herriot Tabuteau - Founder, Chairman, CEO & President
Nick Pizzie - Chief Financial Officer
Ari Maizel - Chief Commercial Officer
Conference Call Participants
Ashwani Verma - UBS Investment Bank, Research Division
Marc Goodman - Leerink Partners LLC, Research Division
Lin Tsai - Jefferies LLC, Research Division
Ami Fadia - Needham & Company, LLC, Research Division
Jason Gerberry - BofA Securities, Research Division
Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division
David Amsellem - Piper Sandler & Co., Research Division
Yatin Suneja - Guggenheim Securities, LLC, Research Division
Sean Laaman - Morgan Stanley, Research Division
David Hoang - Deutsche Bank AG, Research Division
Myles Minter - William Blair & Company L.L.C., Research Division
Matthew Hershenhorn - Oppenheimer & Co. Inc., Research Division
Benjamin Burnett - Wells Fargo Securities, LLC, Research Division
Graig Suvannavejh - Mizuho Securities USA LLC, Research Division
Madison Wynne El-Saadi - B. Riley Securities, Inc., Research Division
Guofang Li - Wolfe Research, LLC
Presentation
Operator
Good morning, and welcome to the Axsome Therapeutics First Quarter 2026 Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call. [Operator Instructions] Please note, this call is being recorded.
I will now turn the call over to Ashley Dong, Senior Director of Investor Relations. Ashley, please go ahead.
Ashley Dong
Thank you. Good morning, and thank you for joining Axsome's First Quarter 2026 Earnings Conference Call. With us today are Dr. Herriot Tabuteau, our Chief Executive Officer; Nick Pizzie, our Chief Financial Officer; and Ari Maizel, our Chief Commercial Officer, who will begin our call with prepared remarks. Mark Jacobson, our Chief Operating Officer; and Hunter Murdock, our General Counsel, will also be available for Q&A.
Please note that today's discussion includes forward-looking statements regarding our financial performance, commercial strategy and operational plans, including
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。